OptimizeRx names new CFO and CAO, effective January 2027
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth
August 12, 2026 4:05 PM EDTThe Company Names Andy DSilva as the next Chief Financial Officer and Heather Favazza as Chief Accounting Officer effective January 1, 2027
Planned Transition Reflects Strong Succession Planning and Deep Leadership Bench
WALTHAM, Mass., Aug. 12, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the Company) (Nasdaq: OPRX), a leading healthcare technology company enabling life sciences organizations to deliver smarter, more personalized engagement across the healthcare ecosystem, today announced a finance leadership transition that reflects the Companys disciplined succession planning, deep leadership bench, and confidence in its... More
